Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Dermatology

Journal Scan / Research · June 12, 2024

Outcomes of Using Oral Sebetralstat for the On-Demand Treatment of Hereditary Angioedema Attacks

The New England Journal of Medicine


Additional Info

The New England Journal of Medicine
Oral Sebetralstat for On-Demand Treatment of Hereditary Angioedema Attacks
N. Engl. J. Med 2024 May 31;[EPub Ahead of Print], MA Riedl, H Farkas, E Aygören-Pürsün, F Psarros, DF Soteres, M Staevska, M Cancian, D Hagin, D Honda, I Melamed, S Savic, M Stobiecki, PJ Busse, E Dias de Castro, N Agmon-Levin, R Gower, A Kessel, M Kurowski, R Lleonart, V Grivcheva Panovska, HJ Wedner, PK Audhya, J Hao, M Iverson, MD Smith, CM Yea, WR Lumry, A Zanichelli, JA Bernstein, M Maurer, DM Cohn

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading